Researchers Identify a Weak Link in Cancer Cell Armor

The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Researchers at the Cornell University College of Veterinary Medicine have discovered that inactivation of a DNA repair gene called Hus1 efficiently kills cells lacking p53—a gene mutated in the majority of human cancers.

Using a mouse model, senior author Robert Weiss, associate professor of molecular genetics, first author and graduate student Stephanie Yazinski and colleagues explored how cells respond when both genes are inhibited. When they inactivated the Hus1 gene in healthy mammary gland tissues, the researchers report, it caused genome damage and cell death. And when they studied the effects of Hus1 inactivation in p53-deficient cells, which are highly resistant to cell death, they discovered that the ability of Hus1 inactivation to kill cells was even greater.

The study is published in the Nov. 9 issue of the Proceedings of the National Academy of Sciences.

"Our work contributes to an important new understanding of cancer cells and their weaknesses,” Weiss said. “The mutations that allow cancer cells to divide uncontrollably also make the cancer cells more dependent on certain cellular processes. We were able to exploit one such dependency of p53-deficient cells and could efficiently kill these cells by inhibiting Hus1.”

Weiss and his team have new experiments under way.

“We’ve proven the power of inhibiting both pathways in normal tissue,” said Weiss. “Now we want to extend our knowledge to cancerous tissue and determine if the loss of Hus1 will impact the ability of cancers with p53 mutations to take hold and grow.”

Weiss’s research was funded by the National Institutes of Health and is now funded through 2013 in part by the American Recovery and Reinvestment Act (ARRA). To date, Cornell has received 124 ARRA grants, totaling more than $99.9 million. Weiss’s ARRA funding will support one faculty and two student positions as well as the research activities of several additional lab members.

Written by Stephanie Specchio, communications director for the College of Veterinary Medicine. This article originally appeared in the Cornell Chronicle.

Source:  Cornell University

RELATED STORIES:
Novel Anti-Cancer Mechanism Found in Long-Lived Rodents   Cancer risks of eating red and processed meat   Children Find Ways to Cope with Cancer   $1 million of mesothelioma research funding   Lilly brain cancer drug promising in small study   ‘Chemical Nose’ May Sniff Out Cancer Earlier   Nanocenter Offers Promising Non-Invasive Cancer Treatment   Improving Cancer Diagnosis   Cancer survivors recognized for helping Philadelphia-area patients   New Research Suggests Ways to Improve Cancer Therapy   Newly Found Enzymes May Play Early Role in Cancer   Normalizing Tumor Vessels to Improve Cancer Therapy   Cancer patients want info on costly drug options   Using ice cream to combat side effects of chemo   Brain metastases hijack neuron-supporting cells to resist chemotherapy   Hepatitis C: a risk factor for lymphoma   Lung cancer tied to family risk of other cancers   Cancer centers and high-volume hospitals may examine more lymph nodes in cancer patients   Managing symptoms by mobile phone may revolutionize cancer care for young people   Late-Breaking Science and Clinical Trials   How sunlight causes skin cells to turn cancerous   Jews who survived wartime Europe have more cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]